NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 450-457

  Mueller, Alan L ^a   Artman, Linda D ^a   Balandrin, Manuel F ^a   Brady, Ellen ^a   Chien, Yongwei Eric ^a   Delmar, Eric G ^a   George, Karen ^a   Kierstead, Allison ^a   Marriott, Thomas B ^a   Scott T, Moe ^a   Newman, Michael K ^a   Raszkiewicz, Joanna L ^a   Sanguinetti, Elizabeth L ^a   Van Wagenen, Bradford C ^a   Wells, David ^a  

^a NPS Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3 BIS(3 FLUOROPHENYL) N METHYLPROPYLAMINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ATAXIA; CARDIOTOXICITY; CELL VACUOLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG STRUCTURE; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ATAXIA; RODENTIA;

EID: 0033403484     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08023.x     Document Type: Conference Paper

References (10)

1. 1. Ginsberg, M.D. 1993. Emerging strategies for the treatment of ischemic brain injury. In Molecular and Cellular Approaches to the Treatment of Neurological Disease. S.G. Waxman, Ed.: 207-237. Raven Press. New York.
2. 2. Smith, D.H., K. Casey & T.K. McIntosh. 1995. Pharmacologic therapy for traumatic brain injury: experimental approaches. N. Horizons 3: 562-572.
3. 3. Willetts, J., R.L. Balster & J.D. Leander. 1990. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 11: 423-428.
4. 4. Olney, J.W., J. Labruyere & M.T. Price. 1989. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360-1362.
5. th Annual Meeting of the American Society of Pharmacognosy, #O-19, Santa Cruz, CA, July 30, 1996.
6. th National Meeting of the American Chemical Society, ORGN 273, Orlando, FL, August 28, 1996.
7. 7. Zea Longa, E., P.R. Weinstein, S. Carlson & R. Cummins. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
8. 8. Rosenberg, G.A., S. Mun-Byce, M. Wesley & M. Kornfeld. 1990. Collagenase-induced intracerebral hemorrhage in rats. Stroke 21: 801-807.
9. 9. Shapira, Y., A.A. Artru & A.M. Lam. 1992. Ketamine decreases cerebral infarct volume and improves neurological outcome following experimental head trauma in rats. J. Neurosurg. Anesth. 4: 231-240.
10. 10. Smith, D.H., K. Okiyama, T.A. Gennarelli & T.K. McIntosh. 1993. Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury. Neurosci. Lett. 157: 211-214.